Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Clinical trial NCT05386108 · RECRUITING

Trial details

NCT number: NCT05386108
Sponsor: Stemline Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Brain Neoplasms Neoplasms by Site Neoplasms Breast Diseases Central Nervous System Neoplasms Brain Diseases Central Nervous System Diseases

Start date: 2022-08-31
Primary completion: 2026-12-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.